BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24030391)

  • 1. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.
    Guo W; Xing C; Dong A; Lin X; Lin Y; Zhu B; He M; Yao R
    Cancer Biol Ther; 2013 Oct; 14(10):916-21. PubMed ID: 24030391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
    Le Dieu R; Taussig DC; Ramsay AG; Mitter R; Miraki-Moud F; Fatah R; Lee AM; Lister TA; Gribben JG
    Blood; 2009 Oct; 114(18):3909-16. PubMed ID: 19710498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia.
    Guo W; Dong A; Xing C; Lin X; Pan X; Lin Y; Zhu B; He M; Yao RX
    Oncol Lett; 2014 Aug; 8(2):825-830. PubMed ID: 25009659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.
    Merims S; Li X; Joe B; Dokouhaki P; Han M; Childs RW; Wang ZY; Gupta V; Minden MD; Zhang L
    Leukemia; 2011 Sep; 25(9):1415-22. PubMed ID: 21566657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.
    Hongeng S; Petvises S; Worapongpaiboon S; Rerkamnuaychoke B; Pakakasama S; Jootar S
    Int J Hematol; 2003 Feb; 77(2):175-9. PubMed ID: 12627854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered effector function of peripheral cytotoxic cells in COPD.
    Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
    Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Costimulatory Molecule Tim3 on NK Cells and Its Subsets in Patients with Acute Myeloid Leukemia].
    Wu WH; Shao JW; Jiang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1899-1903. PubMed ID: 33283717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.
    Nouri AM; Dorey E; Davis CL; Rohatiner A; Lister TA; Oliver RT
    Cancer Immunol Immunother; 1993 Jul; 37(1):47-53. PubMed ID: 8513452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell.
    Linn YC; Lau SK; Liu BH; Ng LH; Yong HX; Hui KM
    Immunology; 2009 Mar; 126(3):423-35. PubMed ID: 18778291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
    Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
    Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.
    Massari D; Prpic-Massari L; Kehler T; Kastelan M; Curkovic B; Persic V; Ruzic A; Laskarin G
    Rheumatol Int; 2012 Sep; 32(9):2777-84. PubMed ID: 21830153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells.
    Fei F; Lim M; George AA; Kirzner J; Lee D; Seeger R; Groffen J; Abdel-Azim H; Heisterkamp N
    Leukemia; 2015 Apr; 29(4):788-97. PubMed ID: 25134458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
    Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
    Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset.
    Garcia-Suarez J; Prieto A; Reyes E; Manzano L; Merino JL; Alvarez-Mon M
    Blood; 1993 Sep; 82(5):1538-45. PubMed ID: 7689873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.
    Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
    Respir Res; 2010 Jun; 11(1):76. PubMed ID: 20540777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.